Articles
According to its latest news update, Follicum will present top-line data from its recent phase 2a trial by the end of the month. The phase 2a trial for Follicum’s hair growth candidate FOL-005 was completed at sites in Hamburg and Berlin, Germany at the end of August this year. The study comprised 60 patients (assumed…
Updated After a long wait we finally have the answer. The “Brotzu Lotion” aka Trinov is going to be released by Fidia Pharma this year. The press release shown above was posted on Fidia’s official website today only in the Italian version. The key points from the announcement are as follows: Production on Trinov has…
British hair-cell cloning company HairClone has released its latest newsletter on September 10th. This is the second newsletter of the year from HairClone, the company previously published a newsletter in February. HairClone typically divides its news updates into two categories, business and science. It’s interesting to follow HairClone’s progress in these regards and see how…
The Guardian has reported the intriguing drug WAY-316606, which was originally developed for osteoporosis, may soon be entering human hair growth clinical trials with the help of an Italian pharmaceutical company. I was pleasantly surprised to find some worthwhile information in the latest “mainstream media baldness cure” article published by The Guardian today. I should…
Another important milestone has been achieved by the Swedish biotech company Follicum. Today, Follicum announced that all patients participating in their phase 2a clinical trial have completed treatment. The phase 2a trial took place at centers in Berlin and Hamburg, Germany and was carried out over the past 3 months. 60 subjects participated and received…
It looks like we may have another approved treatment on the market within the next 2 years. Today, Samumed released a newsletter addressing its program for androgenic alopecia, and stated that the company “has conducted an Investigator Meeting to initiate our upcoming 625-patient Phase 3 clinical trial.” While the results from the phase 2 trial…
About 3.5 years ago the Sanford Burnham Prebys medical research institute released an article that received major attention in the hair seeker community and in the mainstream media. SBP researcher Alexey Terskikh PhD had just published a peer reviewed article detailing his work turning human embryonic stem cells (hESCs) into hair-producing dermal papillae cells. It…
New Beauty, a magazine covering the female aesthetics industry, has released a print article featuring “hair loss solutions.” The article contains quotes and information from Dr. George Cotsarelis, RiverTown Therapeutics, and Histogen. The Brotzu Lotion is also mentioned, though with information already known. Setipiprant For Females In the article, Dr. Cotsarelis shares that his lab…
I have just received an email from a representative of MAX BioPharma, a biotechnology company based in Santa Monica CA, which directed me to the company’s crowdfunding campaign for a hair loss experiment. After taking a quick review of the company and the campaign, I’ve decided it’s worthwhile to share here. About The Company MAX BioPharma…
After I shared an update about a potential announcement time frame for Shiseido a few weeks ago, I read a few queries from readers who wondered if a Shiseido market release would be available to everyone in the world. Today, I received more positive news from a credible source to help clear things up. Once again,…